» Articles » PMID: 38410685

Management of Nephrolithiasis After Kidney Transplantation: a Comprehensive Review from the European Renal Association CKD-MBD Working Group

Overview
Journal Clin Kidney J
Specialty Nephrology
Date 2024 Feb 27
PMID 38410685
Authors
Affiliations
Soon will be listed here.
Abstract

The lifetime incidence of kidney stones is 6%-12% in the general population. Nephrolithiasis is a known cause of acute and chronic kidney injury, mediated via obstructive uropathy or crystal-induced nephropathy, and several modifiable and non-modifiable genetic and lifestyle causes have been described. Evidence for epidemiology and management of nephrolithiasis after kidney transplantation is limited by a low number of publications, small study sizes and short observational periods. Denervation of the kidney and ureter graft greatly reduces symptomatology of kidney stones in transplant recipients, which may contribute to a considerable underdiagnosis. Thus, reported prevalence rates of 1%-2% after kidney transplantation and the lack of adverse effects on allograft function and survival should be interpreted with caution. In this narrative review we summarize current state-of-the-art knowledge regarding epidemiology, clinical presentation, diagnosis, prevention and therapy of nephrolithiasis after kidney transplantation, including management of asymptomatic stone disease in kidney donors. Our aim is to strengthen clinical nephrologists who treat kidney transplant recipients in informed decision-making regarding management of kidney stones. Available evidence, supporting both surgical and medical treatment and prevention of kidney stones, is presented and critically discussed. The specific anatomy of the transplanted kidney and urinary tract requires deviation from established interventional approaches for nephrolithiasis in native kidneys. Also, pharmacological and lifestyle changes may need adaptation to the specific situation of kidney transplant recipients. Finally, we point out current knowledge gaps and the need for additional evidence from future studies.

Citing Articles

Tips for percutaneous nephrolithotomy for transplant kidney stone.

Yagisawa T, Shimizu T, Tachiki A, Ishiyama Y, Onohara T, Iida S IJU Case Rep. 2025; 8(1):32-35.

PMID: 39749290 PMC: 11693098. DOI: 10.1002/iju5.12800.


Advanced Management of Complex Transplant Lithiasis: Low Lithotomy and Boot Stirrups Technique.

Zeng M, Kwan K, Tang J, Wen X, Xiong L Am J Case Rep. 2025; 26:e946224.

PMID: 39741401 PMC: 11702444. DOI: 10.12659/AJCR.946224.


Renal transplant nephrolithiasis: Presentation, management and follow-up with control comparisons.

Sandberg M, Cohen A, Escott M, Marie-Costa C, Temple D, Rodriguez R BJUI Compass. 2024; 5(10):934-941.

PMID: 39416760 PMC: 11479801. DOI: 10.1002/bco2.436.


Comprehensive Approaches to Urolithiasis in Renal Transplants: A Narrative Review.

Solano C, Corrales M, Panthier F, Doizi S, Traxer O J Clin Med. 2024; 13(14).

PMID: 39064308 PMC: 11278228. DOI: 10.3390/jcm13144268.

References
1.
Boissier R, Rodriguez-Faba O, Zakri R, Hevia V, Budde K, Figueiredo A . Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney. Eur Urol Focus. 2022; 9(3):491-499. DOI: 10.1016/j.euf.2022.11.019. View

2.
Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T . Hyperuricemia-induced inflammasome and kidney diseases. Nephrol Dial Transplant. 2015; 31(6):890-6. DOI: 10.1093/ndt/gfv024. View

3.
Abou-Elela A . Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review. J Adv Res. 2017; 8(5):513-527. PMC: 5512151. DOI: 10.1016/j.jare.2017.04.005. View

4.
Li X, Li B, Meng Y, Yang L, Wu G, Jing H . Treatment of recurrent renal transplant lithiasis: analysis of our experience and review of the relevant literature. BMC Nephrol. 2020; 21(1):238. PMC: 7310338. DOI: 10.1186/s12882-020-01896-5. View

5.
Ferreira Cassini M, Cologna A, Ferreira Andrade M, Lima G, Medeiros Albuquerque U, Pereira Martins A . Lithiasis in 1,313 kidney transplants: incidence, diagnosis, and management. Transplant Proc. 2012; 44(8):2373-5. DOI: 10.1016/j.transproceed.2012.07.052. View